To date the company has been self funded. The initial consumer product was two years in development and a total of USD$1.2 million has been invested, securing multiple patents and trademarks including FDA PMA Class III, CDC, AMA, ADA, EPA, OSHA, UL and CE approvals, as well as supply chain agreements for initial manufacturing. Business Week recognized the product with their highly esteemed IDEA Award in the Medical & Scientific product category.
